PubHawk
World Psychiatry February 2015 PMID 25655145

Novel psychoactive substances of interest for psychiatry.

Fabrizio Schifano, Laura Orsolini, G Duccio Papanti, John M Corkery

Download social card

Mentions

12
Peak: 2 in Aug 2024
across 5 sources since Nov 2019

Extended reach

1,644
potential audience

Total likes

5

Video views

627

Mentions per month

Nov 2019 – Aug 2024

Where it's discussed

  • X / Twitter3 posts
  • Facebook3 posts
  • Reddit3 posts
  • News2 articles
  • YouTube1 videos

AI synopsis

What people are saying

The discussions emphasize the importance of understanding novel psychoactive substances, with posts using words like 'crucial' and 'game changer' to highlight their significance. The tone is generally serious and inquisitive, citing specific examples such as how these substances interact with neurotransmitter systems and their potential mental health impacts, illustrating their high relevance and potential to shape psychiatric approaches.

AgreementModerate agreement

Most discussions acknowledge the importance of the publication, with some expressing strong support for its scientific and clinical value.

InterestHigh interest

Participants show high curiosity and eagerness to understand the topic, highlighting the relevance of emerging psychoactive substances in psychiatry.

EngagementModerate engagement

The discussions involve references to specific compounds, effects, and implications, indicating thoughtful engagement, though not deeply technical or critical.

ImpactHigh impact

The discussions reflect a recognized significance of the publication, suggesting it could influence future research and clinical practice.

Abstract in brief

  • Novel psychoactive substances include a wide variety of synthetic drugs, plant-based substances, and performance-enhancing drugs that produce strong psychoactive effects and are often hard to detect in routine drug tests.
  • These substances interact with multiple neurotransmitter systems like dopamine, cannabinoid, GABA, serotonin, glutamate, and opioid receptors, potentially leading to various psychopathological issues.
  • The paper aims to update psychiatrists on the clinical pharmacology, mental health impacts, and management strategies related to the use of these emerging psychoactive substances.]
Read the full abstract

Top posts

Most liked on X and Bluesky
ちひろ大根
@duvet_0414 · X

リリカが｢解離と多幸感を生じさせる"理想的な精神薬"｣として紹介されている 海外だと不安障害にも処方されてるんすね https://t.co/mhWKk8KKea https://t.co/1jHxXL6iZN

Aug 4, 2024 · 2 likes · 410 followers View post →
DJ KIA
@djkia · X

インターネット等の闇市場で取引されている種々の向精神薬について、臨床薬学の観点からまとめた論文。https://t.co/XKp7ixMj72

Aug 22, 2024 · 352 followers View post →

All mentions

DJ KIA
@djkia · X

インターネット等の闇市場で取引されている種々の向精神薬について、臨床薬学の観点からまとめた論文。https://t.co/XKp7ixMj72

Aug 22, 2024 · 352 followers View post →
ちひろ大根
@duvet_0414 · X

リリカが｢解離と多幸感を生じさせる"理想的な精神薬"｣として紹介されている 海外だと不安障害にも処方されてるんすね https://t.co/mhWKk8KKea https://t.co/1jHxXL6iZN

Aug 4, 2024 · 2 likes · 410 followers View post →
Phil E. Parry
@RiggerStar · X

Novel psychoactive substances of interest for psychiatry https://t.co/lHQo2CuKQI

Nov 1, 2019 · 255 followers View post →